VIVO
Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company
recognized for its premium products and services, has entered into a technology
and multi-phase research agreement with CB2 Insights Inc. (CSE: CBII) (OTCQB:
CBIIF) (“CB2”), a leading data-driven company focused on bringing real-world
evidence driven from the point-of-care to the medical cannabis community. Under
the agreement, CB2 will assist in the development of VIVO’s global medical
product development strategy. CB2 will integrate its Clinical Data Management
Software (“CDMS”) and Electronic Data Capture (“EDC”) tools to establish a
better understanding of VIVO’s current medical patient registry, and the
companies will collaborate on a comprehensive research strategy to validate the
safety and efficacy of current products. “CB2’s global experience in clinical
research and technology will enable VIVO to enhance our understanding of
Canadian medical patients. This will facilitate our uncovering of new ways to
meet the expectations of our current patients and will help inform our
international growth plans,” VIVO CEO Barry Fishman said in the news release.
“At VIVO, our purpose is to help patients achieve a positive quality of life
with cannabis. We look forward to utilizing our partnership with CB2 to further
bring real world evidence to the medical cannabis industry.”
To view the full press release, visit http://ibn.fm/rqKbi
About VIVO Cannabis(TM)
VIVO, based in Napanee, Ontario, is recognized for trusted,
high-quality products and services. It holds production and sales licenses from
Health Canada and operates world-class indoor cultivation facilities with
proprietary plant-growing technology. VIVO has a collection of premium brands
targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM),
Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a
premium cannabis company based in Hope, British Columbia. Canna Farms was
B.C.’s first Licensed Producer and has several years of craft cultivation
experience and expertise, as well as a significant patient base and positive
cash flow. The company is significantly expanding its production capacity and
pursuing partnership and product development opportunities domestically, as
well as in select international markets, including Germany and Australia. VIVO
also operates Harvest Medicine, a patient-centric and highly scalable network
of specialty medical cannabis clinics as well as a free telemedicine service.
VIVO has a healthy balance sheet and is well-positioned to accelerate its
growth in Canada and internationally. For more information, visit the company’s
website at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates
relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment